Pharma Journalist -

Pfizer Inc. announced that the United States Food and Drug Administration (FDA) has approved XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR (tofacitinib) extended release 11 mg once…
Read More...

Zytoprotec announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to PD-protec, the Company's peritoneal dialysis fluid for the…
Read More...

PAREXEL International Corporation introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp. Perceptive Cloud…
Read More...

SMi are delighted to welcome Oliver Rausch, VP Research & Development, Storm Therapeutics, onto the speaker line-up for day 1 at RNA Therapeutics 2018! Oliver has overall…
Read More...

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is now offering clients large molecule bioanalytical services at its laboratory in Wavre,…
Read More...

Abzena plc has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate…
Read More...

MeiraGTx announced that the Offices of Orphan Products Development and Pediatric Therapeutics of the U.S. Food and Drug Administration (FDA) have granted rare pediatric disease…
Read More...

Carmot Therapeutics, announced that it has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen (Thousand Oaks, CA). As part of the agreement,…
Read More...

Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Lyomark Pharma, an established provider of high-quality medicines for the hospital…
Read More...

Gilead Sciences, Inc. and its cell therapy subsidiary Kite announced that they have entered into a definitive agreement under which they have agreed to acquire Cell Design Labs, Inc.,…
Read More...